These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30976466)

  • 1. Association and diagnostic value of serum SPINK4 in colorectal cancer.
    Xie M; Li K; Li J; Lu D; Hu B
    PeerJ; 2019; 7():e6679. PubMed ID: 30976466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulated SPINK4 is associated with poor survival in colorectal cancer.
    Wang X; Yu Q; Ghareeb WM; Zhang Y; Lu X; Huang Y; Huang S; Sun Y; Lin J; Liu J; Chi P
    BMC Cancer; 2019 Dec; 19(1):1258. PubMed ID: 31888570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPINK4 promotes colorectal cancer cell proliferation and inhibits ferroptosis.
    Hu BL; Yin YX; Li KZ; Li SQ; Li Z
    BMC Gastroenterol; 2023 Apr; 23(1):104. PubMed ID: 37013514
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Yang X; Jiang S; Yuan Z; Jiang J; Yang M; Luo J; Ye T
    Biomol Biomed; 2024 May; ():. PubMed ID: 38747892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High SPINK4 Expression Predicts Poor Outcomes among Rectal Cancer Patients Receiving CCRT.
    Chen TJ; Tian YF; Chou CL; Chan TC; He HL; Li WS; Tsai HH; Li CF; Lai HY
    Curr Oncol; 2021 Jun; 28(4):2373-2384. PubMed ID: 34202399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of tumor-expressed REG4, SPINK4 and alpha-1 antitrypsin with cancer-associated thrombosis in colorectal cancer.
    Buijs JT; van Beijnum R; Anijs RJS; Laghmani EH; Sensuk L; Minderhoud C; Ünlü B; Klok FA; Kuppen PJK; Cannegieter SC; Versteeg HH
    J Thromb Thrombolysis; 2024 Mar; 57(3):370-380. PubMed ID: 38066386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Levels of Adipocytokines as Potential Biomarkers for Early Detection of Colorectal Carcinoma in Egyptian Patients.
    Zekri AR; Bakr YM; Ezzat MM; Zakaria MS; Elbaz TM
    Asian Pac J Cancer Prev; 2015; 16(16):6923-8. PubMed ID: 26514469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
    Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
    Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spalt-like transcription factor 4 as a potential diagnostic and prognostic marker of colorectal cancer.
    Wu HK; Liu C; Fan XX; Wang H; Zhou L
    Cancer Biomark; 2017 Aug; 20(2):191-198. PubMed ID: 28869451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic effect of serum miR-196b as biomarker in colorectal cancer.
    Xu C; Gu L
    Biomed Rep; 2017 Jan; 6(1):39-45. PubMed ID: 28123705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of the secreted Kazal-type serine protease inhibitor SPINK4 in colitis.
    Wang Y; Han J; Yang G; Zheng S; Zhou G; Liu X; Cao X; Li G; Zhang B; Xie Z; Li L; Zhang M; Li X; Chen M; Zhang S
    Nat Commun; 2024 Jul; 15(1):5874. PubMed ID: 38997284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum haptoglobin as a novel molecular biomarker predicting colorectal cancer hepatic metastasis.
    Sun L; Hu S; Yu L; Guo C; Sun L; Yang Z; Qi J; Ran Y
    Int J Cancer; 2016 Jun; 138(11):2724-31. PubMed ID: 26756179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer.
    Liu T; Zhang X; Gao S; Jing F; Yang Y; Du L; Zheng G; Li P; Li C; Wang C
    Oncotarget; 2016 Dec; 7(51):85551-85563. PubMed ID: 27888803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum level of lncRNA-HIF1A-AS1 as a novel diagnostic predictor for worse prognosis in colorectal carcinoma.
    Gong W; Tian M; Qiu H; Yang Z
    Cancer Biomark; 2017 Dec; 20(4):417-424. PubMed ID: 28946548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated soluble E-cadherin during the epithelial-mesenchymal transition process and as a diagnostic marker in colorectal cancer.
    Zhu S; Zhao G; Zhao X; Zhan X; Cai M; Geng C; Pu Q; Zhao Q; Fu Q; Huang C; Wang Q
    Gene; 2020 Sep; 754():144899. PubMed ID: 32544494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association between serum levels of S100A8/S100A9 and clinical features of colorectal cancer patients].
    Shu P; Zhao L; Wagn J; Shen X; Zhang X; Shen S; Ma J; Li X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Jun; 41(6):553-9. PubMed ID: 27374437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Value of Serum Insulin-Like Growth Factor Binding Protein 7 (IGFBP7) in Colorectal Cancer.
    Qiu B; Chu LY; Li XX; Peng YH; Xu YW; Xie JJ; Chen XY
    Onco Targets Ther; 2020; 13():12131-12139. PubMed ID: 33262611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance and diagnostic value of serum NSE, CEA, CA19-9, CA125 and CA242 levels in colorectal cancer.
    Luo H; Shen K; Li B; Li R; Wang Z; Xie Z
    Oncol Lett; 2020 Jul; 20(1):742-750. PubMed ID: 32566000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat shock protein 70 is a useful marker for predicting colorectal cancer.
    Gunaldi M; Kocoglu H; Okuturlar Y; Gedikbasi A; Karabulut M; Alis H; Hursitoglu M
    J BUON; 2015; 20(6):1464-70. PubMed ID: 26854442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Chemokine CXCL7 as a Diagnostic Biomarker for Colorectal Cancer.
    Li L; Zhang L; Tian Y; Zhang T; Duan G; Liu Y; Yin Y; Hua D; Qi X; Mao Y
    Front Oncol; 2019; 9():921. PubMed ID: 31649870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.